OncoSwab

Lung cancer is one of the most common cancers worldwide, yet screening policies haven’t caught up with this reality. Right now, screenings focus almost entirely on people with a history of heavy smoking. But here’s the truth: thousands of people diagnosed with lung cancer every year have never smoked a cigarette in their life. Where does that leave them? ??Left out of critical screenings. ??Misunderstood. ??Invisible in the larger conversation. It’s time to change that. Lung cancer doesn’t follow stereotypes, and our policies shouldn’t either. We need screening guidelines that reflect the full spectrum of risk, greater research, and inclusive policies that give everyone a fighting chance. No one should feel unseen in this fight. Let’s move this conversation forward - because every story deserves a voice! #Lungcancerawarenessmonth #lungcancer #earlydetection

Nothing is more anxiety-inducing than waiting for a potential life-changing diagnosis. Exactly this is what Johannes, an advocate and OncoSwab investor, experienced. A few years ago, after dealing with a persistent cough, Johannes decided to get it checked out, thinking it was nothing serious. However, doctors found a nodule on his lung during a CT scan. This unexpected news was concerning, and the possibility that it could be lung cancer weighed heavily on his mind. He was told he had to wait three months before a biopsy could determine if the nodule was malignant. Those months were challenging, filled with anxiety and uncertainty. He found it difficult to focus on his university studies; lectures and assignments became hard to manage under the stress. Eventually, he stopped studying and put his life on hold. He couldn't find the mental space to continue as usual. When the biopsy results finally came back after three long months as benign, the relief was immense. Johannes felt like he could breathe again. But he also realized how much those months had affected him - missed moments with loved ones, setbacks in his education, and an impact on his mental well-being. During this Lung Cancer Awareness Month, Johannes wants to highlight the need for better resources and support systems for those awaiting important medical results. If you or someone you know is going through something similar, please know that you're not alone. Reach out to friends, family, or support groups. Sharing fears and concerns can make a significant difference. He emphasizes that early detection and quicker diagnostic processes are crucial not just for physical health, but for mental and emotional well-being as well. At OncoSwab, it is exactly because of stories like Johannes's that we are striving to make early detection as accessible and timely as possible to give everyone the certainty they deserve. #Lungcancerawareness #Lungcancer

??? 1 in 5 people diagnosed with lung cancer have never smoked. Lung cancer awareness isn’t just about smokers—it’s about everyone. Whether you’re a smoker or not, cancer doesn’t discriminate. Anyone with lungs can get lung cancer. Now, the question is: what can we do to increase early diagnosis in non-smokers? At OncoSwab, it’s all about non-invasive testing and accessibility. And that’s what we’re striving for. #LungCancerAwareness #LungCancerScreening #CancerScreening #LungCancer

Team work making the dream work! #lungcancer #diagnostics #cancerscreening #lungcancerscreening

Finalists of the Digital Health Nation Innovation Booster powered by Innosuisse met this week in Basel for the last bootcamp of the program, and it was an intense and exciting experience!?This time, the focus was on building clear project roadmaps, aligning with strategic vision, and gearing up for investor readiness. ?? ?? ?? Congratulations to the Top 5 teams on the impressive progress they’ve shown throughout the program: Beyond Diagnostics, ALPINA+SANA, SensApp by OrthoSens, OncoSwab and neuroAIgnostics. Keep pushing boundaries and inspiring change! Special thank you goes to Aurélie Moser ?? for leading the workshop and to all the experts who joined us onsite — your insights were invaluable. ?? Petar Angelov and Moritz W?lchli from Deloitte, Dr. Melanie Steck from BRAUNPAT AG, Christine Jacob ?????? and Steven (Steve) Bourke. Excited to see these innovative projects continue to grow and make an impact in the digital health space. #healthcareinnovation #swissinnovationbooster #digitalhealth Yana Yoncheva | Ursula Costa | DayOne - Healthcare Innovation | Dr. Maren Schinz | Ema Grabenweger | Gwenael Hannema | Oleg Kotsur | Perrine Lhuillier (吕贝琳）| Nicolas Langer | Roberta Gatta, PhD

Congratulations to the Venture Leaders Medtech 2024 on an incredible pitch competition! The ten talented medtech founders on the "Swiss National Startup Team" gathered last night to present their innovations to an audience of Boston-area investors, industry leaders, and experts. After two rounds of voting, the winner was declared: OncoSwab, a Swiss startup developing a non-invasive test to quickly detect early stage lung cancer, represented by co-founder Pablo Lara, PhD. As the winner of this year’s Medtech Pitchfest, OncoSwab will receive a three-month residency at #Swissnex, offering them a unique chance to immerse themselves in the Boston ecosystem. A huge thank you to the Venture Leaders for showcasing their cutting-edge solutions, to Lando & Anastasi, LLP for supporting the event, and to our engaged audience for their support and participation! Venture Leaders Medtech is organized by Venturelab and #Swissnex and supported by EPFL, ETH Zürich, Hansj?rg Wyss, Health Innovation Hub Aargau, Kellerhals Carrard Startup & VC Desk, Etat de Vaud (Innovaud/Vaud Promotion), Kanton Zürich, and VISCHER. Apersys AG Aseptuva BIOS Medical Calico Biosystems Citus Impli Metadvice MYNERVA OneTwenty.ai #VLeadersMedtech #VentureLeaders #SwissStartups #SwissInnovation

Welcome to Boston! The Venture Leaders Medtech 2024 team arrived at Swissnex today to kick off a week-long immersion in Boston's leading #medtech ecosystem. Over the course of the week, they’ll engage with investors, entrepreneurs, and industry experts, gaining insights into funding and the US business mindset. Meet the startups:? Apersys AG | Saving patients in need of an organ transplant with a long-term liver perfusion system able to preserve a liver organ for up to 7 days. Aseptuva | Improving patient care and preventing hospital acquired infections with UVC-technology for catheters. BIOS Medical | Restoring life after hip fracture with the world’s first implanted hip mobility sensor. Calico Biosystems | Predicting the clinical efficacy of anti-cancer drugs at a pre-clinical stage using intact patient tumors. Citus | Revolutionizing skin diagnostics with the Nimble, an aspiration device exceeding current industry standards on sensitivity and accuracy. Impli | Making fertility treatment more accessible, safer and more successful with real-time hormone monitoring. Metadvice | Advancing clinical outcomes and streamline the healthcare workflow with AI-powered software to enhance clinical decision?making. MYNERVA | Reducing falls and chronic pain in patients suffering from diabetic neuropathy through a combination of Artificial Intelligence and Non-invasive neurostimulation. OncoSwab | Detecting early-stage lung cancer with a non-invasive, easy-to-use test. OneTwenty.ai | Making diabetes care smarter, more reliable and more reassuring with a machine learning solution that predicts blood glucose 120 minutes in advance. On Wednesday night, they’ll showcase their solutions at the Medtech Pitchfest 2024, presented by #Swissnex and Venturelab and supported by Lando & Anastasi, LLP. Haven't got your ticket yet? There’s still time to request one: https://lnkd.in/gED4UeXR Venture Leaders Medtech is organized by Venturelab and #Swissnex and supported by EPFL, ETH Zürich, Hansj?rg Wyss, Health Innovation Hub Aargau, Kellerhals Carrard Startup & VC Desk, Canton de Vaud (Innovaud/Vaud Promotion), Kanton Zürich, and VISCHER. #VLeadersMedtech #VentureLeaders #SwissStartups #SwissInnovation

It’s events like the GO2 for Lung Cancer Gala that highlight why we do what we do. My favorite moment was seeing all the survivors together on stage for a picture. Someone next to me said, “It’s a blessing to see the same people again, year after year.” It is truly a blessing, and it's not taken for granted. The #LungCancer community is stronger than ever. The future of lung cancer research is bright, and at OncoSwab, we are committed to being at the forefront. Thank you, GO2 for Lung Cancer for a wonderful evening. #LungCancerAwareness #SimplyTheBestGala #GO2

??Remembering Susan Wojcicki Susan Wojcicki, a visionary who transformed Silicon Valley, passed away at 56 after a two-year battle with non-small cell lung cancer. As the former CEO of YouTube and a pioneer who helped build Google from the ground up, Susan’s impact on the world was immeasurable. Yet, lung cancer took her life too soon. Did you know that up to 20% of people diagnosed with lung cancer have never smoked? The misconception that lung cancer only affects smokers needs to be shattered. If you have lungs, you can get lung cancer. Lung cancer remains the leading cause of cancer deaths in both men and women, causing more deaths each year than breast, prostate, and colorectal cancers combined. So why aren’t we talking about it more? ?? It’s time to break the silence. Lung cancer isn’t just a smoker’s disease, and Susan’s story is a powerful reminder of that. ?? Share your story. Let’s raise awareness and end the stigma. Together, we can save lives. #LungCancerAwareness #Lungcancer

Getting ready for Boston with the ???? Swiss National Startup Team, the Venture Leaders Medtech selection 2024. Looking forward to an inspiring investor and business development roadshow and the US election. Learn more about the 10 Venture Leaders Medtech startups: https://lnkd.in/dVZspkKT #VleadersMedtech